Litcius/Paper detail

Exploiting synthetic lethality to target BRCA1/2-deficient tumors: where we stand

Parasvi S. Patel, Arash Algouneh, Razqallah Hakem

2021Oncogene90 citationsDOI

Topics & Concepts

Synthetic lethalityBiologyDNA repairPolymeraseCancer researchFanconi anemiaPARP1Protein-fragment complementation assayGeneticsPhenotypeGenePoly ADP ribose polymeraseComplementationPARP inhibition in cancer therapyCRISPR and Genetic EngineeringDNA Repair Mechanisms
Exploiting synthetic lethality to target BRCA1/2-deficient tumors: where we stand | Litcius